PAUL HOPKINS to Triglycerides
This is a "connection" page, showing publications PAUL HOPKINS has written about Triglycerides.
Connection Strength
1.809
-
Hyperlipoproteinemia type 3: the forgotten phenotype. Curr Atheroscler Rep. 2014 Sep; 16(9):440.
Score: 0.362
-
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study. Atherosclerosis. 2009 Dec; 207(2):559-66.
Score: 0.251
-
Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol. 2005 Apr 05; 45(7):1003-12.
Score: 0.189
-
Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J Hum Genet. 2004; 49(1):29-34.
Score: 0.172
-
Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients. J Clin Lipidol. 2016 Sep-Oct; 10(5):1163-71.
Score: 0.102
-
The relation between erythrocyte trans fat and triglyceride, VLDL- and HDL-cholesterol concentrations depends on polyunsaturated fat. PLoS One. 2012; 7(10):e47430.
Score: 0.080
-
Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction. Arterioscler Thromb. 1991 Sep-Oct; 11(5):1137-46.
Score: 0.074
-
Evaluation of the gene-age interactions in HDL cholesterol, LDL cholesterol, and triglyceride levels: the impact of the SORT1 polymorphism on LDL cholesterol levels is age dependent. Atherosclerosis. 2011 Jul; 217(1):139-41.
Score: 0.071
-
The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res. 2008 Aug; 49(8):1839-45.
Score: 0.058
-
The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. Eur J Hum Genet. 2008 May; 16(5):603-13.
Score: 0.057
-
Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet. 2005 Sep; 117(5):444-51.
Score: 0.048
-
Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2003 Aug 05; 108(5):519-23.
Score: 0.042
-
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides. Clin Genet. 2001 Feb; 59(2):88-98.
Score: 0.035
-
Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res. 2000 Sep; 41(9):1428-36.
Score: 0.034
-
Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36. J Lipid Res. 2016 12; 57(12):2176-2184.
Score: 0.026
-
Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis. J Am Heart Assoc. 2016 09 28; 5(10).
Score: 0.026
-
Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS One. 2012; 7(10):e48663.
Score: 0.020
-
The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate. J Cardiovasc Pharmacol. 2012 Mar; 59(3):254-9.
Score: 0.019
-
High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study. Lipids Health Dis. 2011 Oct 18; 10:181.
Score: 0.019
-
Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status. Atherosclerosis. 2011 Apr; 215(2):435-9.
Score: 0.018
-
Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J Lipid Res. 2010 Nov; 51(11):3316-23.
Score: 0.017
-
Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis. 2009 Apr; 203(2):633-9.
Score: 0.015
-
Evidence of QTL on 15q21 for high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study (NHLBI FHS). Atherosclerosis. 2007 Jan; 190(1):232-7.
Score: 0.013
-
Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study. Diabetes Care. 2006 Mar; 29(3):631-6.
Score: 0.013
-
Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees. Eur J Hum Genet. 2002 Jun; 10(6):367-74.
Score: 0.010
-
Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb Vasc Biol. 2001 Dec; 21(12):1969-76.
Score: 0.009
-
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001 Jan 02; 103(1):102-7.
Score: 0.009
-
Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension. 1991 Jun; 17(6 Pt 2):969-76.
Score: 0.005
-
Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Arch Intern Med. 1990 Mar; 150(3):582-8.
Score: 0.004
-
Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989 May-Jun; 9(3):335-44.
Score: 0.004
-
Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 1989 Mar; 129(3):625-38.
Score: 0.004
-
Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988 Jun 24; 259(24):3579-86.
Score: 0.004